• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性髓性白血病的细胞遗传学研究

Cytogenetic study of chronic myeloid leukemia.

作者信息

Michalová K, Musilová J, Koudelová Z, Placerová J, Matuchová L

机构信息

3rd Medical Department, Faculty of General Medicine, Charles University, Prague, Czechoslovakia.

出版信息

Neoplasma. 1988;35(5):571-81.

PMID:3216931
Abstract

A total of 122 patients with chronic myeloid leukemia (CML) were cytogenetically examined. At the first cytogenetic examination 68 of them were in chronic phase (CP) and 54 in blastic phase (BP) of the disease. The mean age of the whole group was 44.8 +/- 15.2 years. All patients included in this study were Ph-positive. In two of them constitutional chromosomal aberrations were ascertained. In two patients the standard Ph translocation was accompanied within onset of BP by a clone with complex translocation and in three patients Ph chromosome was found in mosaics with normal karyotype. Standard translocation t(9.22) (q34;q11) as the sole chromosomal abnormality was found in 17 (31%) patients in BP and in 47 (69%) of patients in CP. The most frequent additional abnormalities found were +8, i(17q), +Ph and their combination, and other nonrandom chromosomal changes. Clonal evolution was proved in 11 out of 24 serially examined patients during the progression of the disease. The analysis of relationship between prognosis of the disease and the results of cytogenetic examination revealed significant differences, and a more favorable course of the disease was observed for the group of patients in CP and with Ph chromosome as the sole chromosomal aberration.

摘要

对122例慢性髓性白血病(CML)患者进行了细胞遗传学检查。在首次细胞遗传学检查时,其中68例处于疾病的慢性期(CP),54例处于急变期(BP)。整个组的平均年龄为44.8±15.2岁。本研究纳入的所有患者均为Ph阳性。其中2例确定存在先天性染色体畸变。2例患者在BP期发病时,标准的Ph易位伴有一个复杂易位的克隆,3例患者在正常核型的嵌合体中发现了Ph染色体。在BP期,17例(31%)患者和CP期47例(69%)患者中发现标准易位t(9;22)(q34;q11)是唯一的染色体异常。最常见的其他异常是+8、i(17q)、+Ph及其组合,以及其他非随机染色体变化。在24例连续检查的患者中,有11例在疾病进展过程中出现了克隆演变。对疾病预后与细胞遗传学检查结果之间关系的分析显示存在显著差异,CP期且以Ph染色体作为唯一染色体畸变的患者组疾病进程更有利。

相似文献

1
Cytogenetic study of chronic myeloid leukemia.慢性髓性白血病的细胞遗传学研究
Neoplasma. 1988;35(5):571-81.
2
Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.532例髓系白血病和骨髓增生异常综合征患者的细胞遗传学异常。捷克斯洛伐克骨髓增生异常综合征合作组
Czech Med. 1990;13(4):133-44.
3
Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.慢性粒细胞白血病继发性染色体畸变的测定
Cancer Genet Cytogenet. 2004 Aug;153(1):53-6. doi: 10.1016/j.cancergencyto.2003.12.013.
4
[Chronic myeloid leukemia. Karyotype changes].
Invest Clin. 1996 Sep;37(3):167-75.
5
The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.甲磺酸伊马替尼对伴有继发性染色体畸变的费城染色体阳性慢性髓性白血病患者的疗效。
Clin Cancer Res. 2003 Apr;9(4):1333-7.
6
Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.在越南南部慢性髓性白血病的慢性期,经常发现独特的继发性染色体异常。
Cancer Genet Cytogenet. 2006 Jul 1;168(1):59-68. doi: 10.1016/j.cancergencyto.2005.12.010.
7
Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.慢性髓性白血病的多色COBRA-FISH分析揭示了疾病进展过程中新型隐匿性平衡易位。
Genes Chromosomes Cancer. 2002 Oct;35(2):127-37. doi: 10.1002/gcc.10099.
8
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.在慢性期费城染色体阳性慢性髓性白血病患者接受甲磺酸伊马替尼治疗期间出现的费城染色体阴性中期的染色体异常。
Cancer. 2003 Nov 1;98(9):1905-11. doi: 10.1002/cncr.11729.
9
[Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].[甲磺酸伊马替尼治疗费城染色体阳性慢性髓性白血病患者后异常费城染色体阴性细胞的克隆进化]
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):23-6.
10
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.费城染色体阴性、bcr/abl阴性慢性粒细胞白血病患者的特征及预后
Cancer. 2002 Oct 15;95(8):1673-84. doi: 10.1002/cncr.10832.